Anteris Technologies Global (NASDAQ:AVR – Get Free Report) and Helius Medical Technologies (NASDAQ:HSDT – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, dividends, analyst recommendations, risk and valuation.
Valuation and Earnings
This table compares Anteris Technologies Global and Helius Medical Technologies”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Anteris Technologies Global | $2.70 million | 58.36 | -$76.29 million | N/A | N/A |
| Helius Medical Technologies | $520,000.00 | 37.72 | -$11.74 million | ($1,976.28) | -0.01 |
Profitability
This table compares Anteris Technologies Global and Helius Medical Technologies’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Anteris Technologies Global | N/A | N/A | N/A |
| Helius Medical Technologies | -7,215.25% | -699.93% | -415.24% |
Analyst Ratings
This is a summary of recent ratings and target prices for Anteris Technologies Global and Helius Medical Technologies, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Anteris Technologies Global | 1 | 0 | 4 | 0 | 2.60 |
| Helius Medical Technologies | 1 | 1 | 0 | 0 | 1.50 |
Anteris Technologies Global currently has a consensus price target of $16.50, indicating a potential upside of 277.57%. Given Anteris Technologies Global’s stronger consensus rating and higher possible upside, equities research analysts clearly believe Anteris Technologies Global is more favorable than Helius Medical Technologies.
Insider & Institutional Ownership
18.6% of Helius Medical Technologies shares are owned by institutional investors. 4.0% of Anteris Technologies Global shares are owned by insiders. Comparatively, 17.9% of Helius Medical Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Summary
Anteris Technologies Global beats Helius Medical Technologies on 8 of the 11 factors compared between the two stocks.
About Anteris Technologies Global
Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.
About Helius Medical Technologies
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.
Receive News & Ratings for Anteris Technologies Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anteris Technologies Global and related companies with MarketBeat.com's FREE daily email newsletter.
